resTORbio Company
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.
%20.jpg)
Last Funding Type:
Series B
Funding Status:
IPO
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2016-01-01
Investor Type:
Company
Total Funding:
65000000
Technology:
Geroscience
Employee Number:
11-50
Number Of Exists:
Series B
Estimated Revenue:
$1M to $10M
Investors Number:
2
Industry:
Agetech